T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times! https://t.co/QKQqtJ7d5H
@VickySanzMoreno Don’t get me wrong, I just feel bad that the country’s smartest resources could be paid much less than what they deserved. I would be glad if most postdocs have different opinion with mine 🤔💕
@VickySanzMoreno Great opportunity! But having lived in London for years, I am not sure if the salary could compensate enough for a postdoc to live a decent life in or near Chelsea - unless housing and/or transportations costs are provided/subsidized ?
1/ Do you want to know if a variant will affect the structure and function of a protein?
We’ve got lots of tools and #data in @ensembl to help you investigate and we’re here to show you how! A thread...🧵
#genomics#bioinformatics # #tweetorial#Ensembltraining🧬
Congrats! Thank you @ProfGLongMIA & @ProfRScolyerMIA for your work to make neoadjuvant therapy more available for patients facing melanoma!
https://t.co/LUiWTJN3Mk
NOW we must change the #melanoma management guidelines across the world. #Neoadjuvant#immunotherapy better than adjuvant in resectable stage 3&4 melanoma SWOG1801 HR 0.58 p0.004 fir event-free survial
I’m indeed so glad and it feels absolutely great to see this work out!!this story represents years of a fantastic PhD @lunduniversity and I couldn’t be more proud!! Thanks so much Göran, and to all involved 🙏🏼
My mother was just telling me that my Great-Aunt was first in mathematics and won the University Medal at the University of Sydney but wasn't allowed to accept a fully funded scholarship to Oxford because she was a women. The scholarship went to the 2nd placed man.
❗️Another week, another PhD student has come to my office in tears as they can’t afford to live in London on £18k. And this is before the price cap increase. @UKRI_News this time - can I ask what you are doing to support the next-generation so there is a next-generation?! Pls RT
Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.
"This is why non-immunologists hate immunologists..." The fantastic @EJohnWherry explains the basics of cancer immunology with a focus on T cells in his beautiful and extremely clear lecture @AACR#AACR22. I really recommend watching it, it's a gem - both in content and delivery.